Opko Health Inc (OPK): Discussion here starting on page 7 (due...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	32
Posts	3277
Boards Moderated	0
Alias Born	08/31/2006

joe_techi

Re: Juice555 post# 6007

Monday, 04/23/2018 8:09:52 PM

Monday, April 23, 2018 8:09:52 PM

Discussion here starting on page 7 (due around May 8...not sure of date)

https://seekingalpha.com/article/4152628-opko-healths-opk-ceo-phillip-frost-q4-2017-results-earnings-call-transcript

Excerpt

"As such we anticipate revenue from services during the three months ended to March 31, 2018 to be in the range of $195 million to $215 million, which include the impact of volume fluctuations, the impact of PAMA and other reimbursement challenges we faced during 2017 as well as the accounting changes I previously mentioned.

Moving to RAYALDEE, we anticipate first quarter revenues will be between $3.5 million and $5 million, which reflect a range of estimates to our gross to net calculations as well as our expectations for volume trends. In addition, we expect the first quarter operating expenses for our investments in R&D as well as the RAYALDEE commercial team to be approximately $35 million and $8 million respectively."